fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether has been researched along with Peripheral Nerve Diseases in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eger, EI; Goldberg, ME; Larijani, GE | 1 |
1 other study(ies) available for fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether and Peripheral Nerve Diseases
| Article | Year |
|---|---|
Peripheral neuropathy in healthy men volunteers anesthetized with 1.25 MAC sevoflurane for 8 hours.
Topics: Adult; Anesthesia; Anesthetics, Inhalation; Ethers; Humans; Hydrocarbons, Fluorinated; Male; Methyl Ethers; Peripheral Nervous System Diseases; Sevoflurane; Time Factors | 1999 |